1887

Abstract

Tuberculosis (TB) is an ancient human disease and remains today one of the most important public health problems and the second most frequent cause of death from an infectious disease worldwide. While pulmonary TB is the most common form, extra-pulmonary TB is on the rise due to the increase in immunosuppressed subjects. Cutaneous TB manifestations are rare forms of extra-pulmonary TB due to systemic dissemination of bacilli or direct inoculation, involving skin or skin-associated tissue, more common in immunocompromised subjects. Some risk factors and the features of the lesion may prompt the suspicion of cutaneous TB, but only microbiological assays can confirm the diagnosis. Our work summarizes cutaneous TB manifestations and differences from other skin mycobacterial infections, also describes two characteristic clinical cases.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005070
2016-11-01
2019-12-11
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/3/6/jmmcr005070.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005070&mimeType=html&fmt=ahah

References

  1. Aboutalebi A., Shen A., Katta R., Allen S. E.. 2012; Primary cutaneous infection by Mycobacterium avium: a case report and literature review. Cutis89:175–179[PubMed]
    [Google Scholar]
  2. Barry C. E. III, Boshoff H. I., Dartois V., Dick T., Ehrt S., Flynn J., Schnappinger D., Wilkinson R. J., Young D.. 2009; The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol7:845–855 [CrossRef][PubMed]
    [Google Scholar]
  3. Bartralot R., Pujol R. M., García-Patos V., Sitjas D., Martín-Casabona N., Coll P., Alomar A., Castells A.. 2000; Cutaneous infections due to nontuberculous mycobacteria: histopathological review of 28 cases. Comparative study between lesions observed in immunosuppressed patients and normal hosts. J Cutan Pathol27:124–129 [CrossRef][PubMed]
    [Google Scholar]
  4. Bartralot R., García-Patos V., Sitjas D., Rodríguez-Cano L., Mollet J., Martín-Casabona N., Coll P., Castells A., Pujol R. M.. 2005; Clinical patterns of cutaneous nontuberculous mycobacterial infections. Br J Dermatol152:727–734 [CrossRef][PubMed]
    [Google Scholar]
  5. Bhambri S., Bhambri A., Del Rosso J. Q.. 2009; Atypical mycobacterial cutaneous infections. Dermatol Clin27:63–73 [CrossRef][PubMed]
    [Google Scholar]
  6. Bhutto A. M., Solangi A., Khaskhely N. M., Arakaki H., Nonaka S.. 2002; Clinical and epidemiological observations of cutaneous tuberculosis in Larkana, Pakistan. Int J Dermatol41:159–165 [CrossRef][PubMed]
    [Google Scholar]
  7. Bishai W. R.. 2000; Rekindling old controversy on elusive lair of latent tuberculosis. Lancet356:2113–2114 [CrossRef][PubMed]
    [Google Scholar]
  8. Böddinghaus B. K., Ludwig R. J., Kaufmann R., Enzensberger R., Gies V., Kramme S., Brade V., Brandt C. M.. 2007; Leprosy in a pregnant woman. Infection35:37–39 [CrossRef][PubMed]
    [Google Scholar]
  9. Bravo F. G., Gotuzzo E.. 2007; Cutaneous tuberculosis. Clin Dermatol25:173–180 [CrossRef][PubMed]
    [Google Scholar]
  10. Chao M. C., Rubin E. J.. 2010; Letting sleeping dos lie: does dormancy play a role in tuberculosis?. Annu Rev Microbiol64:293–311 [CrossRef][PubMed]
    [Google Scholar]
  11. Dartois V.. 2014; The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat Rev Microbiol12:159–167 [CrossRef][PubMed]
    [Google Scholar]
  12. Delogu G., Goletti D.. 2014; The spectrum of tuberculosis infection: new perspectives in the era of biologics. J Rheumatol Suppl91:11–16 [CrossRef][PubMed]
    [Google Scholar]
  13. Dias M. F., Bernardes Filho F., Quaresma M. V., Nascimento L. V., Nery J. A., Azulay D. R.. 2014; Update on cutaneous tuberculosis. An Bras Dermatol89:925–938 [CrossRef][PubMed]
    [Google Scholar]
  14. El-Khalawany M. A.. 2014; Atypical mycobacterial cutaneous infections in Egyptians: a clinicopathological study. J Dermatol41:303–310 [CrossRef][PubMed]
    [Google Scholar]
  15. Gengenbacher M., Kaufmann S. H.. 2012; Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev36:514–532 [CrossRef][PubMed]
    [Google Scholar]
  16. Goletti D., Sanduzzi A., Delogu G.. 2014; Performance of the tuberculin skin test and interferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches. J Rheumatol Suppl91:24–31 [CrossRef][PubMed]
    [Google Scholar]
  17. Good J. T., Iseman M. D., Davidson P. T., Lakshminarayan S., Sahn S. A.. 1981; Tuberculosis in association with pregnancy. Am J Obstet Gynecol140:492–498 [CrossRef][PubMed]
    [Google Scholar]
  18. Handog E. B., Gabriel T. G., Pineda R. T.. 2008; Management of cutaneous tuberculosis. Dermatol Ther21:154–161 [CrossRef][PubMed]
    [Google Scholar]
  19. Hautmann G., Lotti T.. 1994; Atypical mycobacterial infections of the skin. Dermatol Clin12:657–668[PubMed]
    [Google Scholar]
  20. Huiras E., Preda V., Maurer T., Whitfeld M.. 2008; Cutaneous manifestations of immune reconstitution inflammatory syndrome. Curr Opin HIV AIDS3:453–460 [CrossRef][PubMed]
    [Google Scholar]
  21. Lai-Cheong J. E., Perez A., Tang V., Martinez A., Hill V., Menagé H. P.. 2007; Cutaneous manifestations of tuberculosis. Clin Exp Dermatol32:461–466 [CrossRef][PubMed]
    [Google Scholar]
  22. Liao C. H., Lai C. C., Ding L. W., Hou S. M., Chiu H. C., Chang S. C., Hsueh P. R.. 2007; Skin and soft tissue infection caused by non-tuberculous mycobacteria. Int J Tuberc Lung Dis11:96–102[PubMed]
    [Google Scholar]
  23. Lotti T., Hautmann G.. 1993; Atypical mycobacterial infections: a difficult and emerging group of infectious dermatoses. Int J Dermatol32:499–501[PubMed][CrossRef]
    [Google Scholar]
  24. Lowe D. M., Redford P. S., Wilkinson R. J., O'Garra A., Martineau A. R.. 2012; Neutrophils in tuberculosis: friend or foe?. Trends Immunol33:14–25 [CrossRef][PubMed]
    [Google Scholar]
  25. Mehta P. K., Raj A., Singh N., Khuller G. K.. 2012; Diagnosis of extrapulmonary tuberculosis by PCR. FEMS Immunol Med Microbiol66:20–36 [CrossRef][PubMed]
    [Google Scholar]
  26. Min K. W., Ko J. Y., Park C. K.. 2012; Histopathological spectrum of cutaneous tuberculosis and non-tuberculous mycobacterial infections. J Cutan Pathol39:582–595 [CrossRef][PubMed]
    [Google Scholar]
  27. Mitha M., Naicker P., Taljaard J.. 2011; Cutaneous Mycobacterium kansasii infection in a patient with AIDS post initiation of antiretroviral therapy. J Infect Dev Ctries5:553–555 [CrossRef][PubMed]
    [Google Scholar]
  28. Neyrolles O., Hernández-Pando R., Pietri-Rouxel F., Fornès P., Tailleux L., Barrios Payán J. A., Pivert E., Bordat Y., Aguilar D. et al. 2006; Is adipose tissue a place for Mycobacterium tuberculosis persistence?. PLoS One1:e43 [CrossRef][PubMed]
    [Google Scholar]
  29. Ottenhoff T. H., Kaufmann S. H.. 2012; Vaccines against tuberculosis: where are we and where do we need to go?. PLoS Pathog8:e1002607 [CrossRef][PubMed]
    [Google Scholar]
  30. Patel S. S., Tavana M. L., Boger M. S., Win S. S., Rimawi B. H.. 2014; Necrotizing soft tissue infection occurring after exposure to Mycobacterium marinum. Case Rep Infect Dis2014:702613 [CrossRef][PubMed]
    [Google Scholar]
  31. Ramam M., Mittal R., Ramesh V.. 2005; How soon does cutaneous tuberculosis respond to treatment? Implications for a therapeutic test of diagnosis. Int J Dermatol44:121–124 [CrossRef][PubMed]
    [Google Scholar]
  32. Ramam M., Tejasvi T., Manchanda Y., Sharma S., Mittal R.. 2007; What is the appropriate duration of a therapeutic trial in cutaneous tuberculosis? Further observations. Indian J Dermatol Venereol Leprol73:243–246 [CrossRef][PubMed]
    [Google Scholar]
  33. Ranawaka R. R., Abeygunasekara P. H., Perera E., Weerakoon H. S.. 2010; Clinico-histopathological correlation and the treatment response of 20 patients with cutaneous tuberculosis. Dermatol Online J16:13[PubMed]
    [Google Scholar]
  34. Ridley D. S., Jopling W. H.. 1966; Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis34:255–273[PubMed]
    [Google Scholar]
  35. Robertson J., Meier M., Wall J., Ying J., Fichtenbaum C. J.. 2006; Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis42:1639–1646 [CrossRef][PubMed]
    [Google Scholar]
  36. Sali M., De Maio F., Caccuri F., Campilongo F., Sanguinetti M., Fiorentini S., Delogu G., Giagulli C.. 2016; Multicenter evaluation of anyplex plus MTB/NTM MDR-TB assay for rapid detection of Mycobacterium tuberculosis complex and multidrug-resistant isolates in pulmonary and extrapulmonary specimens. J Clin Microbiol54:59–63 [CrossRef][PubMed]
    [Google Scholar]
  37. Santos J. B., Figueiredo A. R., Ferraz C. E., Oliveira M. H., Silva P. G., Medeiros V. L.. 2014; Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects - part I. An Bras Dermatol89:219–228 [CrossRef][PubMed]
    [Google Scholar]
  38. Sester M., Sotgiu G., Lange C., Giehl C., Girardi E., Migliori G. B., Bossink A., Dheda K., Diel R. et al. 2011; Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J37:100–111 [CrossRef][PubMed]
    [Google Scholar]
  39. Solovic I., Jonsson J., Korzeniewska-Koseła M., Chiotan D. I., Pace-Asciak A., Slump E., Rumetshofer R., Abubakar I., Kos S. et al. 2013; Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011. Euro Surveill18:12
    [Google Scholar]
  40. Tebruegge M., Curtis N.. 2011; Mycobacterium marinum infection. Adv Exp Med Biol719:201–210 [CrossRef][PubMed]
    [Google Scholar]
  41. Wang H., Wu Q., Lin L., Cui P.. 2011; Cutaneous tuberculosis: a diagnostic and therapeutic study of 20 cases. J Dermatolog Treat22:310–314 [CrossRef][PubMed]
    [Google Scholar]
  42. Wentworth A. B., Drage L. A., Wengenack N. L., Wilson J. W., Lohse C. M.. 2013; Increased incidence of cutaneous nontuberculous mycobacterial infection, 1980 to 2009: a population-based study. Mayo Clin Proc88:38–45 [CrossRef][PubMed]
    [Google Scholar]
  43. Wolf A. J., Desvignes L., Linas B., Banaiee N., Tamura T., Takatsu K., Ernst J. D.. 2008; Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. J Exp Med205:105–115 [CrossRef][PubMed]
    [Google Scholar]
  44. World Health Organization 2014; Global tuberculosis report 2014.
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005070
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.005070
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error